What is Compugen (CGEN) stock price today?

Compugen (CGEN) currently trades at $2.66 per share. The stock has a market capitalization of $268.77M and a P/E ratio of 7.45x.

Is CGEN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Compugen has a Smart Value Score of 69/100 (Grade B), resulting in a "Buy" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is the CGEN stock price target for 2026?

WallStSmart's 12-month price target for Compugen is $2.06.

What is Compugen's revenue and earnings?

Compugen has trailing twelve-month (TTM) revenue of $72.76M with profit margins of 48.60%. Earnings per share (EPS) is $0.38.

CGEN

Compugen

NASDAQ: CGEN · HEALTHCARE · BIOTECHNOLOGY

$2.66

+2.31% today

Updated 2026-04-30

Market cap

$268.77M

P/E ratio

7.45

P/S ratio

3.69x

EPS (TTM)

$0.38

Dividend yield

—

52W range

$1 – $3

Volume

0.4M

Market cap

$268.77M

P/E ratio

7.45

P/S ratio

3.69x

EPS (TTM)

$0.38

Dividend yield

—

52W range

$1 – $3

Volume

0.4M

WallStSmart proprietary scores

out of 100

Grade: B

Buy

Investment rating

8.0

Growth

5.0

Quality

C+

9.5

Profitability

A+

7.0

Valuation

B+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.83

+119.17%

12-Month target

$2.06

-22.56%

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Profit margin 48.60% — above average

+ ROE 44.80% — strong efficiency

+ Free cash flow $31.33M — positive

+ Revenue growth 4,477.00% QoQ

Risks

No major risks identified

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$7.50M	$33.46M	$27.86M	$72.76M	$72.76M
Net income	$-33.69M	$-18.75M	$-14.23M	$35.34M	$56.84M
EPS	—	—	—	—	$0.38
Free cash flow	$-34.41M	$-36.06M	$49.49M	$31.33M	$31.33M
Profit margin	-449.25%	-56.05%	-51.07%	48.57%	48.60%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CGEN	$268.77M	69	8.0	9.5	7.0	5.0	—	Strong Buy
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Compugen trades at $2.66. representing a P/E of 7.45x trailing earnings. Our Smart Value Score of 69/100 indicates the stock is good. TTM revenue stands at $72.76M. with profit margins at 48.60%.

Frequently asked questions

What is Compugen's stock price?

Compugen (CGEN) trades at $2.66.

Is Compugen overvalued?

Smart Value Score 69/100 (Grade B, Buy).

What is the price target of Compugen (CGEN)?

The analyst target price is $5.83, representing +119.2% upside from the current price of $2.66.

What is Compugen's revenue?

TTM revenue is $72.76M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio3.69x

ROE44.80%

Beta2.77

50D MA$2.17

200D MA$1.76

Shares out0.09B

Float0.09B

Short ratio—

Avg volume0.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CGEN vs LLY →CGEN vs JNJ →CGEN vs ABBV →Stock screener →